Kiniksa Pharmaceuticals, Ltd.【KNSA】 資本金及び資本剰余金の推移

機能の使い方
(単位:千ドル) 資本金及び資本剰余金 前年比(%)
2Q25 989,811 +5.9%
1Q25 970,238 +4.6%
4Q24 959,722 +4.7%
3Q24 949,282 +4.5%
2Q24 934,767 +3.8%
1Q24 927,582 +3.7%
4Q23 916,763 +3.2%
3Q23 908,295 +3.2%
2Q23 900,956 +3.1%
1Q23 894,325 +3.2%
4Q22 888,120 +3.2%
3Q22 880,554 +3.2%
2Q22 874,153 +3.5%
1Q22 866,935 +3.5%
4Q21 860,482 +3.7%
3Q21 853,139 +3.8%
2Q21 844,260 +25.9%
1Q21 837,656 +42.4%
4Q20 829,424 +42.6%
3Q20 822,301 +42.7%
2Q20 670,371 +17.1%
1Q20 588,090 +3.8%
4Q19 581,467 +22.8%
3Q19 576,129 +22.4%
2Q19 572,318 +22.0%
1Q19 566,542 -
4Q18 473,483 -
3Q18 470,600 -
2Q18 469,018 -